| 16741 | ICH-GCP E6(R3) & Human Subject Protection Course | | 30/01/2026 16:02:03 | |
| 16742 | GCP (ICH Focus) for Residents, Research nurses, Students | | 30/01/2026 22:53:30 | |
| 16743 | CITI program : RCR for IRB members, Researchers, Faculty members (Responsible Conduct of Research) | | 01/02/2026 15:38:56 | |
| 16744 | CITI program : GCP (ICH Focus) for IRB members, Researchers, Faculty members | | 01/02/2026 15:40:19 | |
| 16745 | CITI program : IRB members, Researchers, Faculty members (Human Subject Protection) | | 01/02/2026 15:40:53 | |
| 16746 | CITI program : Conflicts of Interest for IRB members, Researchers, Faculty members | | 01/02/2026 15:41:20 | |
| 16747 | จริยธรรมการวิจัยในคน โดยคณะกรรมการพิจารณาจริยธรรมการวิจัยในคน กลุ่มสหสถาบัน ชุดที่ 1 จุฬาลงกรณ์มหาวิทยาลัย | | 01/02/2026 15:54:25 | |
| 16748 | CITI program | | 01/02/2026 21:16:35 | |
| 16749 | CITI Conflicts of Interest | | 01/02/2026 21:58:55 | |
| 16750 | CITI Good Clinical Practice Course for Clinical Trials Involving Drugs (ICH focus) | | 01/02/2026 22:00:40 | |
| 16751 | CITI IRB members, Researchers, Faculty members - Basic/Refresher | | 01/02/2026 22:00:28 | |
| 16752 | CITI Responsible Conduct of Research | | 01/02/2026 22:01:23 | |
| 16753 | Good Clinical Practice & Human Subject Protection Training Program 2025 | | 01/02/2026 22:16:42 | |
| 16754 | Good Clinical Practice | | 01/02/2026 23:06:42 | |
| 16755 | Conflicts of Interest for IRB members, Researchers, Faculty members | | 01/02/2026 23:45:03 | |
| 16756 | GCP (ICH Focus) for IRB members, Researchers, Faculty members | | 01/02/2026 23:45:59 | |
| 16757 | GCP (U.S. FDA Focus) for IRB members, Researchers, Faculty members | | 01/02/2026 23:46:49 | |
| 16758 | GCP Clinical Trials Involving Investigational Devices for IRB members, Researchers, Faculty members | | 01/02/2026 23:47:44 | |
| 16759 | IRB members, Researchers, Faculty members | | 01/02/2026 23:48:05 | |
| 16760 | Good Clinical Practice and Human Subject Protection Training program /จ/ถ | | 02/02/2026 00:02:36 | |
